Commission Soon To Present Blood And Plasma Recommendations
The European Commission is about to present a set of recommendations onblood and plasma donations for use in transfusions and operations. The EU's Council of Health Ministers is expected to consider the recommendations at its next session.
The main objective of the Commission's paper is to ensure sufficiency of supply while monitoring blood and plasma donors to guarantee the safety of the blood products being stored.
The current initiative follows the 1994 Commission Communication (or consultative paper) on blood safety and self-sufficiency in the European Community, which recommended the development of a Community blood strategy in order to improve confidence in the safety of the blood transfusion chain and EU self-sufficiency in these products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze